Curing what ails GE’s health unit
Wall Street Journal (subscription required), October 3, 2008
GE Healthcare sells machines that discover why people are sick, and now its new chief executive, John Dineen, now must cure what ails the business. The division has been plagued by factory-production glitches that led to a federally ordered plant shutdown, an aborted acquisition, and shrinking insurance payments that has decreased demand for GE's products. The unit's operating profit fell 4% in the first half of 2008, and this summer the division laid off hundreds of workers.
- Interventional Radiology No Longer a Sub-Specialty
- NFP Hospitals' Revenue Growth at 'All-Time Low'
- Acute Kidney Injury Gets New Focus
- Transforming Cancer Care
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- Evidence-Based Practice and Nursing Research: Avoiding Confusion
- mHealth Tackles Readmissions
- CNO Leads $1M Charge for New Scrubs, Uniforms
- Sharp HealthCare Leaves Pioneer ACO Program
- MA an Insurance Proving Ground for Providers